| Verified against primary record | |
| Position under EU law | Not a member state; Directive 2011/24/EU does not bind Switzerland[5] |
|---|---|
| Formal EU health cooperation | A health agreement is targeted, not concluded, as at May 2026[2] |
| Cooperation with neighbouring states | Conducted bilaterally, together with the cantons[2] |
| How Swiss care reaches EU patients in the data | Only inside another country’s return; German figures include stays in Switzerland[1] |
| National hospital statistics breakdown | By canton of residence, sex, age group and hospital type; no residence-abroad category listed[3] |
| Independently reported | |
| EU patients using the Directive each year | About 200,000, under 0.05 per cent of EU citizens[4] |
| Bands apply only to the rows beneath them. Switzerland is not covered by the European cross-border healthcare Directive, so the European collections that supply figures for member states contain no Swiss return. No Swiss count of patients resident abroad treated in Switzerland was located. The open data licence on the federal hospital indicators permits non-commercial use and requires permission for commercial use, so no values from that dataset are reproduced here. No typical cost range is given because no official Swiss source publishes prices paid by foreign patients. | |
Medical tourism in Switzerland sits outside the European legal architecture that produces cross-border patient figures for its neighbours. Switzerland is not an EU member state, the cross-border healthcare Directive does not bind it, and as at May 2026 a formal health agreement with the European Union was still being sought rather than concluded. The result is that Swiss medical travel appears in the European data only indirectly, inside other countries’ returns, and that Switzerland’s own hospital statistics are organised by canton of residence with no published category for patients resident abroad.
Outside the Directive
Directive 2011/24/EU places obligations on member states: the member state of affiliation must reimburse cross-border care where the treatment is among the benefits it covers domestically, capped at the level of costs it would have assumed and not exceeding the actual cost of care received, and prior authorisation may be required only on three defined grounds. Switzerland, not being a member state, is not subject to these obligations and makes no return under them.[5]
Swiss care nevertheless reaches patients insured in the Union, and it is visible in the European data only as a component of someone else’s figures. The Commission records that Germany’s reported totals include cases falling outside the Directive, among them stays in Switzerland and persons resident in other EU, EEA or Swiss states. Swiss treatment of German-insured patients therefore inflates the German return without ever appearing as a Swiss quantity.[1]
Anyone compiling European medical travel statistics should treat this as a double caution: Switzerland is absent as a reporting country, and its activity is partly embedded in the largest national return in the collection.
What cooperation exists instead
The Swiss federal health office states that formal cooperation with the European Union is being pursued through a health agreement, described as the basis for full access to EU health security mechanisms and the European Centre for Disease Prevention and Control, and records that agreement as targeted rather than concluded as at May 2026.[2]
In its absence, the office describes close bilateral cooperation with neighbouring countries as equally important, carried out together with the cantons, and notes cooperation with other states through the World Health Organization on early warning and reporting for communicable diseases.[2]
That cantonal involvement matters for how any Swiss cross-border arrangement works in practice. Hospital planning and funding in Switzerland are cantonal responsibilities, so an agreement covering patients crossing a particular border is negotiated at the level of the cantons concerned rather than uniformly for the country.[2]
What Swiss statistics do and do not record
The Federal Statistical Office publishes annual main indicators for inpatient care, covering the number of inpatient cases, hospitalisation days, average length of stay, costs and average revenue per case. The published breakdowns are by canton of residence, sex, age group and hospital type. No category for patients resident abroad is listed, and the dataset entry examined covers 2024 and was last updated on 28 November 2025.[3]
Canton of residence is a domestic geography. A statistic built on it answers the question of which canton should bear a cost, not whether a patient came from outside the country, which is why Swiss hospital indicators cannot be used to measure inbound medical travel.[3]
The federal health office’s own overview publication does not address treatment abroad, patients resident abroad treated in Switzerland, or cross-border healthcare payments. It does provide health system context of a different kind, recording that about 6 per cent of patients in Swiss acute hospitals acquire an infection each year and that about 2,000 people die from such infections.[2]
For comparison, the European Court of Auditors estimated that about 200,000 patients a year use the Directive across the Union, fewer than 0.05 per cent of EU citizens, with spending at roughly 0.004 per cent of the Union’s annual healthcare budget and prior authorisation applying in around 1 per cent of cases. These figures describe the system Switzerland stands outside.[4]
Limits of the evidence
No Swiss figure for foreign patients, foreign patient revenue or cross-border payments is given here because none was located in the Swiss federal sources consulted. The federal hospital indicators are cited for their structure rather than their values, both because the published breakdowns contain no residence-abroad category and because the dataset’s licence requires permission for commercial use. Switzerland’s position as a private medical destination, particularly in clinics serving self-funding international patients, is widely asserted commercially but was not substantiated by any official Swiss source examined, and no figure for it has been estimated.
See also
- Medical tourism in Germany, whose reported figures include stays in Switzerland
- Cross-border healthcare, the framework Switzerland is not party to
- Self-funded medical travel, the basis on which most international patients reach Swiss clinics
- Longevity tourism, a category commonly associated with Swiss private clinics
- Hospital discharge data in medical tourism, and why a residence breakdown determines what can be measured
References
- European Commission, Directorate-General for Health and Food Safety. Data on cross-border patient healthcare following Directive 2011/24/EU, reference year 2023. 15 May 2025. Verified against primary record: the report was opened and the caveat that Germany’s reported figures include cases beyond the Directive, among them stays in Switzerland and persons resident in other EU, EEA or Swiss states, was read directly, together with the absence of any Swiss return in the collection. Retrieved 23 October 2026.
- Bundesamt fur Gesundheit. Facts and Figures. May 2026. Verified against primary record: the publication was opened and the statement that a health agreement with the European Union is targeted as the basis for full access to EU health security mechanisms, the description of bilateral cooperation with neighbouring countries carried out with the cantons, the World Health Organization cooperation on communicable disease reporting, the absence of any treatment of cross-border care or foreign patients, and the hospital infection figures were read directly. Retrieved 23 October 2026.
- Bundesamt fur Statistik. Patienten in Spitalern. Open government data catalogue entry, data last updated 28 November 2025. Verified against primary record: the dataset entry was opened and the list of indicators, the available breakdowns by canton of residence, sex, age group and hospital type, the absence of any residence-abroad category, the 2024 reference period and the licence terms restricting commercial use were read directly. No values from the dataset are reproduced. Retrieved 23 October 2026.
- European Court of Auditors. Special Report 07/2019: EU actions for cross-border healthcare. 2019. Verified against primary record: the report was opened and the annual patient estimate, the shares of citizens and of healthcare spending and the share of cases requiring prior authorisation were read. Retrieved 23 October 2026.
- European Parliament and Council. Directive 2011/24/EU, Chapter III, Articles 7 and 8. 9 March 2011. Verified against primary record: the chapter text was opened and the reimbursement rule in Article 7, its addressing of member states, and the three permitted grounds for prior authorisation in Article 8(2) were read. Retrieved 23 October 2026.
Sourcing note: this entry contains no Swiss patient or revenue figure because none was located in the Swiss federal sources consulted, and none has been estimated or inferred from commercial material. The federal hospital dataset is cited for its structure and its licence terms rather than its values. Switzerland’s absence from the European collections is reported as a consequence of its position outside the Directive, and the fact that Swiss activity is partly embedded in the German return is stated because it affects how the European figures should be read.